Impact of COVID-19 in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis.

Moazzam ShahzadSibgha Gull ChaudharyMuhammad U ZafarMaha A HassanAli HussainFatima AliIqra AnwarMamoon AhmedNausheen AhmedSharad KhuranaMuhammad A RaufFaiz AnwarPeiman HemattiNatalie S CallanderSunil H AbhyankarJoseph P McGuirkMuhammad Umair Mushtaq

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2022)

HSCT recipients have a high risk of mortality and clinical complications due to COVID-19. There is a need for ongoing vigilance, masks, and social distancing, vaccination, and aggressive management of SARS-CoV-2 infection in HSCT recipients.

Keyphrases

hematopoietic stem cell
coronavirus disease
sars cov
respiratory syndrome coronavirus
risk factors
kidney transplantation
healthcare
cardiovascular events
mental health
coronary artery disease